about
Lessons learned from the transgenic Huntington's disease ratsNanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.Dopamine and Huntington's disease.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine ModulationNovel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.Recommendations for the predictive genetic test in Huntington's disease.Neurodegenerative disease: Mapping the natural history of Huntington disease.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.
P2860
Q27027178-BB5606CB-DAF5-402C-A7B7-B6AD9CF91990Q38102579-3F67A34A-E9B1-4FC5-985C-0C055B9465C2Q38181868-56CF434A-2606-46E8-A1ED-765DAC0BAC58Q38379277-CE525606-DB3D-43A2-B5F9-C72977B1C4EBQ39041217-693317F2-8DE0-4C1C-9507-12B5C2364387Q43122795-677EE12B-E6F7-41A8-9D61-67878FDB0171Q43453202-1BC5239E-7526-4512-99DB-35BD1CC9A0E8Q45296364-0F25CACC-02DB-42DE-AA3B-4E4C3B13A851Q52721984-46ED8C25-DDEC-412B-89BE-75B76D461C44
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging drug therapies in Huntington's disease.
@en
Emerging drug therapies in Huntington's disease.
@nl
type
label
Emerging drug therapies in Huntington's disease.
@en
Emerging drug therapies in Huntington's disease.
@nl
prefLabel
Emerging drug therapies in Huntington's disease.
@en
Emerging drug therapies in Huntington's disease.
@nl
P2860
P1476
Emerging drug therapies in Huntington's disease.
@en
P2093
Sarah L Mason
P2860
P304
P356
10.1517/14728210902918299
P407
P577
2009-06-01T00:00:00Z